Earth Science Tech (ETST) Net Cash Flow (2011 - 2026)
Earth Science Tech (ETST) posted Net Cash Flow of $381097.0 for Q1 2026, up 146.49% on a QoQ basis from -$819674.0 in Q4 2025, and down 59.93% year-over-year from $950989.0 in Q1 2025.
Earth Science Tech (ETST) Net Cash Flow (2011 - 2026) Analysis & Trends
Earth Science Tech's Net Cash Flow history runs 15 years deep, the most recent figure standing at $381097.0 for Q1 2026.
- Quarterly Net Cash Flow fell 59.93% year-over-year to $381097.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$676431.0 (down 187.22% YoY) and the FY2026 annual result came in at -$676431.0, down 187.22% from the prior year.
- Net Cash Flow was $381097.0 for Q1 2026 at Earth Science Tech, up from -$819674.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $950989.0 in Q1 2025 and bottomed at -$1.0 million in Q4 2024.
- A 5-year average of $46954.5 and a median of $56233.0 in 2023 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 8269.28% in 2024, while the deepest fall reached 5689.84% in 2024.
- Earth Science Tech's Net Cash Flow stood at $22983.0 in 2022, then dropped by 21.39% to $18068.0 in 2023, then plunged by 5689.84% to -$1.0 million in 2024, then increased by 18.84% to -$819674.0 in 2025, then soared by 146.49% to $381097.0 in 2026.
- Business Quant data shows ETST's Net Cash Flow at $381097.0 in Q1 2026, -$819674.0 in Q4 2025, and $357789.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | 381,097.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 381,097.00 |
| Mar 31, 2026 | 381,097.00 |
| Dec 31, 2025 | -819,674.00 |
| Dec 31, 2025 | -819,674.00 |
| Sep 30, 2025 | 357,789.00 |
| Sep 30, 2025 | 357,789.00 |
| Jun 30, 2025 | -595,643.00 |
| Jun 30, 2025 | -595,643.00 |
| Mar 31, 2025 | 950,989.00 |
| Mar 31, 2025 | 950,989.00 |
| Dec 31, 2024 | -1.01 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Sep 30, 2024 | 147,804.00 |
| Sep 30, 2024 | 147,804.00 |
| Jun 30, 2024 | 686,686.00 |
| Jun 30, 2024 | 686,686.00 |
| Mar 31, 2024 | 518,393.00 |
| Mar 31, 2024 | 518,393.00 |
| Dec 31, 2023 | 18,068.00 |
| Dec 31, 2023 | 18,068.00 |